FdaApplication

BLA 761444

Back to search

Identifiers

Properties

PropertyValue
applicant_nameShanghai Henlius Biotech, Inc.
application_typeBLA
approval_date2025-08-29

Products (3)

ProductActive ingredientStrengthDosage form
BILDYOSDENOSUMAB-NXXP60MG/MLInjection
BILDYOSDENOSUMAB-NXXP60MG/MLInjection
BILPREVDA—120MG/1.7ML (70MG/ML)Injection

3 products